Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients. | sciensano.be

Last updated on 9-1-2023 by Dominique Pierre

Health and disease monitoring

Peer reviewed scientific article

English

SCIENSANO

Authors

Lorenzo Canti; Grégory Ehx

Keywords

Associated health topics:

Health and disease monitoring

QR code

QR code for this page URL

Printer-friendly versionSend by email